<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent reports describe the association of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) with <z:hpo ids='HP_0002072'>chorea</z:hpo> or severe heart valve lesions in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease, or the primary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>We conducted a case series and a case-control investigation of patients with rheumatic <z:hpo ids='HP_0001945'>fever</z:hpo> with Sydenham <z:hpo ids='HP_0002072'>chorea</z:hpo> or other manifestations of rheumatic <z:hpo ids='HP_0001945'>fever</z:hpo> for anticardiolipin antibodies (aCL) during the <z:hpo ids='HP_0011009'>acute</z:hpo> attack and disease remission </plain></SENT>
<SENT sid="2" pm="."><plain>Eighty percent of patients were positive for aCL during the rheumatic <z:hpo ids='HP_0001945'>fever</z:hpo> attack vs 40% when inactive (p = 0.035); IgG and IgM aCL increased significantly with disease activity </plain></SENT>
<SENT sid="3" pm="."><plain>Individuals with or without Sydenham <z:hpo ids='HP_0002072'>chorea</z:hpo> were equally positive for aCL (76 and 83%, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>A significant association was found between IgM aCL and <z:mp ids='MP_0001853'>carditis</z:mp>: <z:hpo ids='HP_0000001'>All</z:hpo> patients with <z:e sem="disease" ids="C1410758" disease_type="Disease or Syndrome" abbrv="">valvulitis</z:e> had IgM aCL (100%) vs 37% of patients without valvular involvement (p = 0.02) </plain></SENT>
<SENT sid="5" pm="."><plain>aPL may play a role in the pathogenesis of some clinical manifestations of <z:hpo ids='HP_0011009'>acute</z:hpo> rheumatic <z:hpo ids='HP_0001945'>fever</z:hpo> </plain></SENT>
</text></document>